XTL Biopharmaceuticals Ltd (XTLB) — Tangible Net Worth Ratio
XTL Biopharmaceuticals Ltd (XTLB) has a Tangible Net Worth Ratio of 29.8% as of December 2024. This metric is calculated by deducting intangible assets (ILA3.82 Million) from net assets (ILA5.43 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore XTLB net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
XTL Biopharmaceuticals Ltd Tangible Net Worth Ratio (2013–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of December 2024, the ratio stands at 29.8%, reflecting net assets of ILA5.43 Million with intangible assets of ILA3.82 Million ILA. For live market cap and overall valuation, see market cap of XTL Biopharmaceuticals Ltd.
Annual Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See XTLB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 29.8% | ILA5.43 Million | ILA3.82 Million | ILA8.55 Million | ▼ -53.1 pp |
| 2023 | 82.9% | ILA2.22 Million | ILA380.00K | ILA2.43 Million | ▼ -7.6 pp |
| 2022 | 90.5% | ILA4.00 Million | ILA380.00K | ILA4.19 Million | ▼ -2.4 pp |
| 2021 | 92.9% | ILA5.33 Million | ILA380.00K | ILA6.62 Million | ▼ -1.0 pp |
| 2020 | 93.9% | ILA6.25 Million | ILA380.00K | ILA6.50 Million | ▼ -0.6 pp |
| 2019 | 94.6% | ILA6.98 Million | ILA380.00K | ILA7.21 Million | ▼ -0.9 pp |
| 2018 | 95.4% | ILA8.32 Million | ILA380.00K | ILA8.57 Million | ▲ +5.9 pp |
| 2017 | 89.5% | ILA3.62 Million | ILA380.00K | ILA6.59 Million | ▼ -1.1 pp |
| 2016 | 90.6% | ILA2.69 Million | ILA253.00K | ILA3.02 Million | ▲ +11.8 pp |
| 2015 | 78.8% | ILA4.89 Million | ILA1.04 Million | ILA5.32 Million | ▲ +32.2 pp |
| 2014 | 46.6% | ILA4.68 Million | ILA2.50 Million | ILA5.64 Million | ▼ -11.2 pp |
| 2013 | 57.8% | ILA6.79 Million | ILA2.87 Million | ILA8.02 Million | — |